Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
- PMID: 28931491
- PMCID: PMC5641502
- DOI: 10.1016/S1474-4422(17)30299-5
Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Abstract
Background: Comparable data on the global and country-specific burden of neurological disorders and their trends are crucial for health-care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study provides such information but does not routinely aggregate results that are of interest to clinicians specialising in neurological conditions. In this systematic analysis, we quantified the global disease burden due to neurological disorders in 2015 and its relationship with country development level.
Methods: We estimated global and country-specific prevalence, mortality, disability-adjusted life-years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs) for various neurological disorders that in the GBD classification have been previously spread across multiple disease groupings. The more inclusive grouping of neurological disorders included stroke, meningitis, encephalitis, tetanus, Alzheimer's disease and other dementias, Parkinson's disease, epilepsy, multiple sclerosis, motor neuron disease, migraine, tension-type headache, medication overuse headache, brain and nervous system cancers, and a residual category of other neurological disorders. We also analysed results based on the Socio-demographic Index (SDI), a compound measure of income per capita, education, and fertility, to identify patterns associated with development and how countries fare against expected outcomes relative to their level of development.
Findings: Neurological disorders ranked as the leading cause group of DALYs in 2015 (250·7 [95% uncertainty interval (UI) 229·1 to 274·7] million, comprising 10·2% of global DALYs) and the second-leading cause group of deaths (9·4 [9·1 to 9·7] million], comprising 16·8% of global deaths). The most prevalent neurological disorders were tension-type headache (1505·9 [UI 1337·3 to 1681·6 million cases]), migraine (958·8 [872·1 to 1055·6] million), medication overuse headache (58·5 [50·8 to 67·4 million]), and Alzheimer's disease and other dementias (46·0 [40·2 to 52·7 million]). Between 1990 and 2015, the number of deaths from neurological disorders increased by 36·7%, and the number of DALYs by 7·4%. These increases occurred despite decreases in age-standardised rates of death and DALYs of 26·1% and 29·7%, respectively; stroke and communicable neurological disorders were responsible for most of these decreases. Communicable neurological disorders were the largest cause of DALYs in countries with low SDI. Stroke rates were highest at middle levels of SDI and lowest at the highest SDI. Most of the changes in DALY rates of neurological disorders with development were driven by changes in YLLs.
Interpretation: Neurological disorders are an important cause of disability and death worldwide. Globally, the burden of neurological disorders has increased substantially over the past 25 years because of expanding population numbers and ageing, despite substantial decreases in mortality rates from stroke and communicable neurological disorders. The number of patients who will need care by clinicians with expertise in neurological conditions will continue to grow in coming decades. Policy makers and health-care providers should be aware of these trends to provide adequate services.
Funding: Bill & Melinda Gates Foundation.
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC-BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Figures





Comment in
-
Global burden of neurological disease: what's in a name?Lancet Neurol. 2017 Nov;16(11):858-859. doi: 10.1016/S1474-4422(17)30333-2. Epub 2017 Sep 17. Lancet Neurol. 2017. PMID: 28931492 No abstract available.
-
Global analysis of neurological disease: burden and benefit.Lancet Neurol. 2017 Nov;16(11):857. doi: 10.1016/S1474-4422(17)30338-1. Lancet Neurol. 2017. PMID: 29029838 No abstract available.
-
Commentary: Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.Front Neurol. 2018 Mar 29;9:201. doi: 10.3389/fneur.2018.00201. eCollection 2018. Front Neurol. 2018. PMID: 29651272 Free PMC article. No abstract available.
Similar articles
-
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet Neurol. 2019 May;18(5):459-480. doi: 10.1016/S1474-4422(18)30499-X. Epub 2019 Mar 14. Lancet Neurol. 2019. PMID: 30879893 Free PMC article.
-
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17. Lancet. 2024. PMID: 38642570 Free PMC article.
-
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.Lancet Respir Med. 2017 Sep;5(9):691-706. doi: 10.1016/S2213-2600(17)30293-X. Epub 2017 Aug 16. Lancet Respir Med. 2017. PMID: 28822787 Free PMC article.
-
Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study.JAMA Neurol. 2021 Feb 1;78(2):165-176. doi: 10.1001/jamaneurol.2020.4152. JAMA Neurol. 2021. PMID: 33136137 Free PMC article.
-
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10. Lancet Psychiatry. 2022. PMID: 35026139 Free PMC article.
Cited by
-
Acquired Brain Injury and Interventions in the Offender Population: A Systematic Review.Front Psychiatry. 2021 May 7;12:658328. doi: 10.3389/fpsyt.2021.658328. eCollection 2021. Front Psychiatry. 2021. PMID: 34025480 Free PMC article. Review.
-
A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease.PLoS One. 2021 Jun 4;16(6):e0251484. doi: 10.1371/journal.pone.0251484. eCollection 2021. PLoS One. 2021. PMID: 34086698 Free PMC article.
-
Exoskeleton use in post-stroke gait rehabilitation: a qualitative study of the perspectives of persons post-stroke and physiotherapists.J Neuroeng Rehabil. 2020 Sep 10;17(1):123. doi: 10.1186/s12984-020-00750-x. J Neuroeng Rehabil. 2020. PMID: 32912215 Free PMC article.
-
Psychometric evaluation of the depression anxiety stress scale 8-items (DASS-8)/DASS-12/DASS-21 among family caregivers of patients with dementia.Front Public Health. 2022 Oct 25;10:1012311. doi: 10.3389/fpubh.2022.1012311. eCollection 2022. Front Public Health. 2022. PMID: 36388286 Free PMC article.
-
The Universal Prescription for Parkinson's Disease: Exercise.J Parkinsons Dis. 2020;10(s1):S21-S27. doi: 10.3233/JPD-202100. J Parkinsons Dis. 2020. PMID: 32925109 Free PMC article. Review.
References
-
- Aarli J, Tarun D, Janca A, Muscetta A. Neurological disorders: public health challenges. World Health Organization; Geneva: 2006.
-
- Murray C, Lopez A. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Harvard School of Public Health; Boston: 1996.
-
- GBD 2015 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–1602. - PMC - PubMed
-
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th edn, text revision. American Psychiatric Association; Washington DC: 2000.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous